Fig 1 shows the mass spectra of families 1–8, in which the analysis was performed on tumour samples or other ecto/endodermal tissues of the affected phenocopies, and on PBLs DNA of heterozygous BRCA1/2 mutation carriers from each family. This evidence concerns the gene BRCA1 and neoplasm.